Worth reading
60In focus
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
2400
unitsWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of Stock Acquisition Rights with rights to convert into stock acquisition rights with adjustable exercise prices, and acquisition and cancellation of the unexercised rights
Intended allottee
Macquarie Bank Limited
Amount of funds to be raised
Funds raised: ¥13 million (estimated net proceeds: Not disclosed)
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥1,320. Adjustment provisions apply. The exercise price is adjusted to 90% of the closing price on the business day preceding each adjustment date. The minimum exercise price is ¥1,090. There is no maximum exercise price.
Exercise period
3 April 2023 to 3 April 2026
Number of Stock Acquisition Rights
Total issued: 2,500 rights; exercised: 100 rights; unexercised: 2,400 rights; after cancellation: 0 rights
Reason for acquisition without consideration
All remaining Stock Acquisition Rights were acquired without consideration upon expiry of the exercise period.
Most recent equity financing
Series 3 Stock Acquisition Rights issued on 31 March 2023; initially planned amount: ¥319 million
Impact on Business Performance
The impact on consolidated results for the fiscal year ending March 2027 will be minor.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of Stock Acquisition Rights with rights to convert into stock acquisition rights with adjustable exercise prices, and acquisition and cancellation of the unexercised rights |
| Amount of funds to be raised | Funds raised: ¥13 million (estimated net proceeds: Not disclosed) |
| Intended allottee | Macquarie Bank Limited |
| Exercise price | Initial exercise price: ¥1,320. Adjustment provisions apply. The exercise price is adjusted to 90% of the closing price on the business day preceding each adjustment date. The minimum exercise price is ¥1,090. There is no maximum exercise price. |
| Exercise period | 3 April 2023 to 3 April 2026 |
| Number of Stock Acquisition Rights | Total issued: 2,500 rights; exercised: 100 rights; unexercised: 2,400 rights; after cancellation: 0 rights |
| Reason for acquisition without consideration | All remaining Stock Acquisition Rights were acquired without consideration upon expiry of the exercise period. |
| Most recent equity financing | Series 3 Stock Acquisition Rights issued on 31 March 2023; initially planned amount: ¥319 million |
| Impact on Business Performance | The impact on consolidated results for the fiscal year ending March 2027 will be minor. |
Items this document does not state (19)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company's share price was below the exercise price of these Stock Acquisition Rights for part of the exercise period, and 2,400 rights (96.0%) were not exercised. The shortfall in funds raised is expected to be supplemented with cash on hand or borrowings from financial institutions.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.